New Antitrust Lawsuit Targets MultiPlan and Major Insurers Over Pricing Practices

In a significant legal confrontation that could reshape the landscape of out-of-network healthcare reimbursements, a new antitrust lawsuit has emerged against MultiPlan and several major insurers. Filed on July 9, 2026, in the U.S. District Court for the Northern District of Illinois, the lawsuit accuses these entities of colluding to suppress out-of-network payouts, potentially impacting countless healthcare providers and patients across the nation. This case, spearheaded by HealthLGX, a firm that manages claims for emergency room and physician practices, is part of a larger consolidated litigation known as In re MultiPlan Health Insurance Provider Litigation.

The crux of the complaint revolves around the claim that MultiPlan, which has recently rebranded as Claritev, has provided insurers with a “common pricing methodology” that they collectively use to determine payment amounts for out-of-network services. This alleged collusion has been labeled the “MultiPlan Cartel,” and the ramifications of such an arrangement could be severe, affecting the financial viability of providers and the accessibility of care for patients seeking out-of-network services.

Understanding Out-of-Network Reimbursements

When patients receive care from healthcare providers that are not part of their insurance network, the reimbursement process can become complex. Insurers typically establish out-of-network benefits that dictate how much they will reimburse for services rendered outside their network. This is crucial for patients who may face emergencies or require specialized care not available within their network.

The Role of MultiPlan and Pricing Methodologies

MultiPlan has positioned itself as a key player in managing out-of-network claims, offering insurers a pricing framework designed to standardize reimbursement rates. According to the lawsuit, approximately 700 payors participate in this pricing methodology, which collectively accounts for over 80% of all out-of-network payments by dollar volume. The complaint alleges that this arrangement not only suppresses individual reimbursements but also influences the broader market by affecting benchmark data.

One of the most alarming assertions made in the lawsuit is that the low reimbursement rates established by MultiPlan and its affiliates have been fed into FAIR Health, a nonprofit organization that provides benchmark data for insurers. This situation could create a feedback loop where even insurers outside of the MultiPlan network begin to adopt lower reimbursement rates based on tainted benchmark data, ultimately reducing payment levels across the board and reversing a trend of increasing reimbursements that had been observed prior to 2016.

Legal Framework and Allegations

The legal basis for the lawsuit rests primarily on Section 1 of the Sherman Act, a federal statute that prohibits agreements that restrain trade. By allegedly colluding to suppress out-of-network reimbursement rates, MultiPlan and the insurers may have violated this law, along with various state antitrust and consumer protection statutes. The lawsuit not only seeks treble damages—three times the amount of damages sustained—but also requests disgorgement of profits obtained through the alleged misconduct and an injunction to halt such practices.

The defendants named in this case include major players in the insurance market, such as UnitedHealth Group, Aetna, The Cigna Group, Elevance Health (formerly Anthem), Humana, Centene, Molina Healthcare, Kaiser Foundation Health Plan, and several Blue Cross Blue Shield entities. This extensive list underscores the potential scale of the alleged cartel and the impact it may have on the insurance industry as a whole.

Who Is Affected by the Allegations?

The implications of this lawsuit extend beyond the immediate parties involved. Healthcare providers, especially those who operate outside of established networks, may find themselves facing increasingly difficult financial circumstances if the allegations are proven true. Lower reimbursement rates can lead to higher out-of-pocket costs for patients, reduced access to necessary services, and even the closure of independent practices that cannot sustain the financial pressure.

• Emergency Room Providers: These providers often treat patients regardless of their insurance status, making them vulnerable to payment suppression.
• Patients: Those seeking out-of-network care may face higher bills and reduced access to specialists.
• Insurers: Companies not involved in the alleged cartel may still be affected by artificially lowered market rates.

Implications for the Insurance Market

If the allegations against MultiPlan and the insurers are proven, the ramifications could prompt significant changes in how out-of-network services are reimbursed. Insurers may be forced to reevaluate their pricing methodologies and reimbursement policies to comply with legal standards and avoid antitrust violations. This could lead to a more competitive market environment, where reimbursement rates are more closely aligned with actual service costs, potentially benefiting both providers and patients.

The case could also set a legal precedent regarding how healthcare pricing is managed in the insurance industry. A ruling in favor of HealthLGX could lead to increased scrutiny of pricing practices among insurers and encourage more transparency in the reimbursement process.

Key Takeaways

• MultiPlan and major insurers are accused of colluding to suppress out-of-network reimbursement rates.
• The lawsuit is based on antitrust laws and seeks treble damages and changes in pricing practices.
• Healthcare providers and patients may face significant financial implications if the allegations are proven true.
• The outcome could reshape how out-of-network reimbursements are handled in the future.

Frequently Asked Questions

What is MultiPlan and what role does it play in healthcare reimbursements?

MultiPlan, now rebranded as Claritev, is a company that provides pricing methodologies for insurers to determine out-of-network reimbursement rates. By offering standardized pricing frameworks, MultiPlan has become a significant player in the healthcare reimbursement landscape, influencing how much providers are paid for services rendered outside of their networks.

What are the potential consequences of this lawsuit for healthcare providers?

If the lawsuit succeeds, healthcare providers, particularly those operating outside of insurance networks, could see a significant increase in reimbursement rates. This could alleviate some of the financial pressures they face and enhance their ability to provide quality care. Conversely, providers may also face uncertainty and potential financial strain during the litigation process, depending on the outcome.

How might this lawsuit impact patients seeking out-of-network care?

Patients seeking out-of-network care could benefit if reimbursement rates increase, leading to lower out-of-pocket costs. However, if the lawsuit leads to prolonged legal battles, patients may experience continued high costs in the interim. The case highlights the importance of understanding insurance coverage and the implications of out-of-network services.

What are the next steps in the litigation process?

The case is currently in its early stages, and the defendants have yet to respond formally to the allegations. As the litigation progresses, both sides will present their arguments, and the court will determine whether the case will proceed to trial. Depending on the complexity and length of the proceedings, it may take several months or even years to reach a resolution.